Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
deals
novartis
startups
albert bourla
alzheimer's disease
amgen
bayer
bristol-myers squibb
cancer
What
drug
bio
roundup
acquisitions
biggest
ceo
today
albert
approved
away
bourla
bringing
build
buy
ceos
companies
company
company’s
crispr
daniel
dc
debut
digital
disease
dyne’s
epidemic
executives
fatty
fda
frenzied
future
gathered
gilead
groups
growing
hearing
held
imports
known
led
Language
unknown
unset
Current search:
abbvie
×
merck
×
" texas blog main "
×
pfizer
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More